Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04377594 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Ablation of Fibrotic Areas in Patients With Persistent Atrial Fibrillation.

Study acronym: IDEAL-AF
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study completion pushed from Apr 11, 2026 to Apr 11, 2027
    • Primary completion date changed from estimate of Apr 11, 2026 to Apr 10, 2026
    v6
  2. Primary completion date: Oct 2024 to Apr 11, 2026v5 Show 4 more changesShow less
    • Trial status: Recruiting to Active, Not Recruiting
    • Study completion date: Oct 2025 to Apr 11, 2026
    • Start date: Jun 1, 2020 to May 20, 2020
    • Site details revised
  3. Primary completion date: Mar 2024 to Oct 2024
    • Study completion date: Mar 2025 to Oct 2025
    v4
  4. Re-verified, no change to tracked fieldsv3
  5. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Jun 2020 to Jun 1, 2020
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Brief summary: The objective of this study is to compare two different ablation strategies in participants with persistent atrial fibrillation and fibrotic areas in the left atrium. The participant will be randomized to pulmonary vein isolation or pulmonary vein isolation plus ablation of fibrotic areas.
Trial Details
NCT Number NCT04377594
Lead Sponsor Karolinska University Hospital
Conditions
(from sponsor)		 Atrial Fibrillation
Related terms Atrial Fibrillation
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov